New approaches to chronic hepatitis B

G Dusheiko, K Agarwal, MK Maini - New England Journal of …, 2023 - Mass Medical Soc
New Approaches to Chronic Hepatitis B | New England Journal of Medicine Skip to main content
The New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

The evolution and clinical impact of hepatitis B virus genome diversity

PA Revill, T Tu, HJ Netter, LKW Yuen… - Nature Reviews …, 2020 - nature.com
The global burden of hepatitis B virus (HBV) is enormous, with 257 million persons
chronically infected, resulting in more than 880,000 deaths per year worldwide. HBV exists …

Tenofovir is associated with lower risk of hepatocellular carcinoma than entecavir in patients with chronic HBV infection in China

TCF Yip, VWS Wong, HLY Chan, YK Tse, GCY Lui… - Gastroenterology, 2020 - Elsevier
Background & Aims There have been conflicting results from studies comparing the risk of
hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection …

[HTML][HTML] KASL clinical practice guidelines for management of chronic hepatitis B

Korean Association for the Study of the … - Clinical and …, 2019 - ncbi.nlm.nih.gov
Diseases (AASLD) also presented and continued to revise their clinical practice guidelines,
and the latest updates were in 2015, 2017, and 2018. However, since the medical …

[HTML][HTML] Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop

HJ Yim, JH Kim, JY Park, EL Yoon, H Park… - Clinical and …, 2020 - ncbi.nlm.nih.gov
Clinical practice guidelines are important for guiding the management of specific diseases
by medical practitioners, trainees, and nurses. In some cases, the guidelines are utilized as …

Effects of tenofovir vs entecavir on risk of hepatocellular carcinoma in patients with chronic HBV infection: a systematic review and meta-analysis

WM Choi, J Choi, YS Lim - Clinical Gastroenterology and Hepatology, 2021 - Elsevier
Background & Aims Tenofovir disoproxil fumarate (TDF) and entecavir are recommended as
first-line treatments for chronic hepatitis B virus (HBV) infection. However, there is debate …

[HTML][HTML] Viral hepatitis: Milestones, unresolved issues, and future goals

P Torre, A Aglitti, M Masarone… - World journal of …, 2021 - ncbi.nlm.nih.gov
In this review the current overall knowledge on hepatitis A, B, C, D, and E will be discussed.
These diseases are all characterized by liver inflammation but have significant differences in …

A DNA Nanoflower‐Assisted Separation‐Free Nucleic Acid Detection Platform with a Commercial Pregnancy Test Strip

L Qi, M Yang, D Chang, W Zhao, S Zhang… - Angewandte …, 2021 - Wiley Online Library
There is a constant drive for affordable point‐of‐care testing (POCT) technologies for the
detection of infectious human diseases. Herein, we report a simple platform for DNA …

S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs-und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der …

M Cornberg, L Sandmann, U Protzer… - Zeitschrift für …, 2021 - thieme-connect.com
Die Medizin unterliegt einem fortwährenden Entwicklungsprozess, sodass alle Angaben,
insbesondere zu diagnostischen und therapeutischen Verfahren, immer nur dem …

Tenofovir, another inexpensive, well-known and widely available old drug repurposed for SARS-COV-2 infection

I Zanella, D Zizioli, F Castelli, E Quiros-Roldan - Pharmaceuticals, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is spreading
worldwide with different clinical manifestations. Age and comorbidities may explain severity …